Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CXCR5 encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. Additionally we are shipping CXCR5 Kits (12) and CXCR5 Proteins (5) and many more products for this protein.
Showing 10 out of 227 products:
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN4895599
Hosomi, Oshitani, Kamata, Sogawa, Okazaki, Tanigawa, Yamagami, Watanabe, Tominaga, Watanabe, Fujiwara, Maeda, Hirakawa, Arakawa: Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis. in Clinical and experimental immunology 2011
Show all 18 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN4895598
Panse, Friedrichs, Marx, Hildebrandt, Luetkens, Barrels, Horn, Stahl, Cao, Milde-Langosch, Niendorf, Kröger, Wenzel, Leuwer, Bokemeyer, Hegewisch-Becker, Atanackovic: Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients. in British journal of cancer 2009
Show all 18 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for CyTOF, FACS - ABIN4899108
Chu, Reczek, Brondyk: Capture-stabilize approach for membrane protein SPR assays. in Scientific reports 2014
Show all 16 Pubmed References
Mouse (Murine) Monoclonal CXCR5 Primary Antibody for FACS - ABIN2689483
Dobner, Wolf, Emrich, Lipp: Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. in European journal of immunology 1992
Show all 6 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN2689481
Förster, Emrich, Kremmer, Lipp: Expression of the G-protein--coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. in Blood 1994
Show all 5 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN2689482
Gunn, Ngo, Ansel, Ekland, Cyster, Williams: A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. in Nature 1998
Show all 5 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN4895594
Kaltenmeier, Gawanbacht, Beyer, Lindner, Trzaska, van der Merwe, Härter, Grüner, Fabricius, Lotfi, Schwarz, Schütz, Hönig, Schulz, Kern, Bommer, Schrezenmeier, Kirchhoff, Jahrsdörfer: CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 4 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN4895595
Winter, Moser, Kriehuber, Wiesner, Knobler, Trautinger, Bombosi, Stingl, Petzelbauer, Rot, Maurer: Down-modulation of CXCR3 surface expression and function in CD8+ T cells from cutaneous T cell lymphoma patients. in Journal of immunology (Baltimore, Md. : 1950) 2007
Show all 4 Pubmed References
Human Polyclonal CXCR5 Primary Antibody for WB - ABIN1881245
Lee, Shiao, Wu, Chen, Hsu, Tsai, Tsai: Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. in The Journal of rheumatology 2009
Show all 3 Pubmed References
Human Monoclonal CXCR5 Primary Antibody for FACS - ABIN4895589
Tso, Law, Tu, Chan, Lau: Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells. in Stem cells (Dayton, Ohio) 2010
Show all 2 Pubmed References
these findings demonstrate that CXCR5 overexpression increases the ability of MSCs to respond to migratory stimuli and highly intensifies their immunomodulatory effects in vivo. This strategy for enhancing targeted stem/progenitor cell homing may improve the efficacy of MSC (show MSC Antibodies)-based therapies.
all three p53 (show TP53 Antibodies) family members mediate the effects of genotoxic stress on the CXCR5 promoter using the same mechanism associated with attenuation of NFkB activity.
identified the miR (show MLXIP Antibodies)-19a/CXCR5 pathway as a candidate p53 (show TP53 Antibodies)-induced migration mechanism
CXCL13 (show CXCL13 Antibodies)/CXCR5 mediated the aggregation of B cells, that directed the aberrant humoral immune responses via the formation of ectopic germinal centers, which suggests a molecular mechanism of neurological damage in neurosyphilis.
the data demonstrate that CXCR5(+)CD8 (show CD8A Antibodies)(+) T cells represent a significant CD8 (show CD8A Antibodies)(+) T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.
we demonstrate that PKCepsilon (show PRKCE Antibodies) cooperates with the loss of the tumor suppressor Pten for the development of prostate cancer in a mouse model. Mechanistic analysis revealed that PKCe (show PRKCE Antibodies) overexpression and Pten loss individually and synergistically upregulate the production of the chemokine (show CCL1 Antibodies) CXCL13 (show CXCL13 Antibodies), which involves the transcriptional activation of the CXCL13 (show CXCL13 Antibodies) gene
Levels of CXCR5 mRNA and protein levels were up-regulated in brain from temporal lobe epilepsy patients.
Neoplastic cells of PCSM-TCL (show RHOJ Antibodies) are medium- to-large-sized T cells with cerebriform nuclei, which lack the expression of TFH-cell defining chemokine receptor CXCR5. These features are highly distinctive and can be invaluable in separating this rather indolent cutaneous T-cell lymphoid neoplasm from more aggressive lymphomas of TFH-cell phenotype, including primary cutaneous TFH-cell lymphoma and skin involvement of AITL
CXCR5 expression positively related to the lymph node and distal metastasis, tumor stage and relapse of colorectal cancer.
In patients with HBV-related hepatocellular carcinoma the phenotype and function of CXCR5+CD45RA-CD4 (show CD4 Antibodies)+ T cells were altered.
CXCL13 (show CXCL13 Antibodies) acts on CXCR5 to increase p38 (show CRK Antibodies) activation and further contributes to the pathogenesis of orofacial neuropathic pain
Cxcr5(CreERT2)R26(Tomato) mice are a useful tool for studying the cell fate of differentiated follicular helper T cells in vivo
CXCL13 (show CXCL13 Antibodies) and CXCR5 contribute to orofacial pain via ERK (show EPHB2 Antibodies)-mediated proinflammatory cytokines production.
Cxcr5 role in the protection of retinal pigment epithelium and retinal cells during aging and Cxcr5 loss may lead to age-related macular degeneration like pathological changes in aged mice.
These data suggest that CXCR5-expressing conventional dendritic cells play an important role in the efficient propagation of orally administered prions toward follicular dendritic cells within Peyer's patches in order to establish host infection.
CXCR5 is involved critically in B cell trafficking and germinal cell formation in murine lupus and in guiding pathogenic double-negative T cells into lymphoid organs and kidneys.
The importance of CXCR5 in autoimmune arthritis varies depending on environmental circumstances.
findings reveal a neuronal/astrocytic interaction in the spinal cord by which neuronally produced CXCL13 (show CXCL13 Antibodies) activates astrocytes via CXCR5 to facilitate neuropathic pain.
IL-33 (show IL33 Antibodies) enhances humoral immunity against chronic hbv infection through activating CD4 (show CD4 Antibodies)(+)CXCR5(+) helper-Inducer T-Lymphocytes.
Results identify p66Shc (show SHC1 Antibodies) as a negative regulator of B-cell chemotaxis and suggest a role for this adaptor in the control of B-cell homing via CXCR4 (show CXCR4 Antibodies)/5.
This gene encodes a multi-pass membrane protein that belongs to the CXC chemokine receptor family. It is expressed in mature B-cells and Burkitt's lymphoma. This cytokine receptor binds to B-lymphocyte chemoattractant (BLC), and is involved in B-cell migration into B-cell follicles of spleen and Peyer patches. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif) receptor 5)
, C-X-C chemokine receptor type 5
, chemokine receptor
, Burkitt lymphoma receptor 1
, chemokine (C-X-C motif) receptor 5
, c-X-C chemokine receptor type 5-like
, Burkitt lymphoma receptor 1, GTP-binding protein
, monocyte-derived receptor 15
, burkitt lymphoma receptor 1 homolog
, chemochine (C-X-C motif) receptor 5
, neurolymphatic receptor